Hutchmed (China)
HCM
Enerpac Tool
EPAC
Ermenegildo Zegna NV
ZGN
Lantheus
LNTH
eBay
EBAY
US Stock MarketDetailed Quotes
INM InMed Pharmaceuticals
- 2.8300
- -0.1700-5.67%
Close Feb 25 16:00 ET
3.42MMarket Cap-0.23P/E (TTM)
3.0050High2.6600Low73.54KVolume2.9800Open3.0000Pre Close207.74KTurnover6.55%Turnover RatioLossP/E (Static)1.21MShares15.696052wk High0.55P/B3.18MFloat Cap2.414052wk Low--Dividend TTM1.12MShs Float3210.0000Historical High--Div YieldTTM11.50%Amplitude2.4000Historical Low2.8240Avg Price1Lot Size
InMed Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q2)Dec 31, 2024 | (Q1)Sep 30, 2024 | (FY)Jun 30, 2024 | (Q4)Jun 30, 2024 | (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q4)Jun 30, 2023 | (Q3)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -35.39%-2.5M | 15.98%-1.83M | 4.08%-6.99M | -56.42%-1.03M | -16.76%-1.93M | 31.88%-1.85M | 3.61%-2.17M | 53.26%-7.28M | 83.74%-657.93K | 69.03%-1.66M |
| Net income from continuing operations | -74.20%-2.58M | 33.86%-1.68M | 3.42%-7.68M | -472.61%-1.94M | 13.77%-1.72M | 29.65%-1.48M | 27.73%-2.54M | 57.27%-7.95M | 95.70%-338.39K | 42.52%-2M |
| Operating gains losses | 1,548.85%15.07K | 161.15%5.27K | 936.52%12.26K | 1,110.99%9.66K | 5,717.24%1.63K | -65.34%-1.04K | -27.83%2.02K | -90.99%1.18K | -165.50%-955 | 96.01%-29 |
| Depreciation and amortization | -15.42%129.08K | -2.94%144.98K | 1.43%604.52K | 0.59%151.86K | 1.02%150.69K | 3.56%152.61K | 0.58%149.36K | 16.45%596K | -2.00%150.97K | -2.71%149.16K |
| Other non cash items | 26.20%-355 | 3.53%-519 | -55.67%-1.25K | 105.11%21 | -1,069.23%-252 | -61.41%-481 | -348.33%-538 | -100.06%-803 | -100.03%-411 | --26 |
| Change In working capital | 86.75%-94.07K | -449.85%-327.64K | 34.73%-369.34K | 352.62%665.61K | -395.36%-418.82K | 16.90%-709.77K | -77.16%93.65K | 81.59%-565.82K | 80.85%-263.48K | 106.39%141.8K |
| -Change in receivables | 110.69%22.13K | -27.93%68.14K | 57.82%-92.44K | -29.85%-145.16K | 286.33%165.19K | -126.09%-207.02K | 29.77%94.55K | -447.76%-219.15K | -539.79%-111.79K | -337.79%-88.65K |
| -Change in inventory | -46.41%116.72K | -93.79%24.25K | -88.29%66.22K | -399.09%-92.78K | -258.38%-449.11K | 31.98%217.78K | 187.94%390.33K | 128.23%565.56K | 98.26%-18.59K | 165.71%283.58K |
| -Change in prepaid assets | 44.86%-495.1K | 16.20%328.87K | -93.22%20.28K | 174.35%540.94K | -28.42%94.29K | -90.95%-897.96K | -35.76%283.02K | 56.92%299.19K | -61.66%197.17K | 111.25%131.73K |
| -Change in payables and accrued expense | 48.98%359.61K | -14.21%-642.39K | 105.61%45.28K | 312.82%470.73K | -36.45%-104.34K | 169.04%241.38K | -253.19%-562.48K | 0.62%-806.53K | 64.12%-221.19K | 84.44%-76.47K |
| -Change in other current assets | --0 | --0 | -10.88%4.91K | --0 | --0 | --1.79K | -43.38%3.12K | 108.96%5.51K | --0 | --0 |
| -Change in other current liabilities | -3.20%-97.42K | -7.90%-106.51K | 6.83%-397.42K | 0.88%-108.12K | 11.24%-96.19K | 12.76%-94.4K | 2.17%-98.71K | -24.78%-426.58K | 0.13%-109.09K | -0.81%-108.38K |
| -Change in other working capital | ---- | ---- | -200.00%-16.17K | --0 | ---28.66K | 5,984.08%28.66K | -203.00%-16.17K | 414.49%16.17K | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -35.39%-2.5M | 15.98%-1.83M | 4.08%-6.99M | -56.42%-1.03M | -16.76%-1.93M | 31.88%-1.85M | 3.61%-2.17M | 53.26%-7.28M | 83.74%-657.93K | 69.03%-1.66M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | 0 | 98.60%-9.29K | 0 | 100.00%-2 | 98.14%-9.29K | 0 | 1.66%-661.8K | 95.37%-33.61K | -3,508.16%-128.2K |
| Net PPE purchase and sale | ---- | ---- | 94.26%-9.29K | --0 | 100.00%-2 | ---- | ---- | -313.74%-161.8K | ---33.61K | -3,508.16%-128.2K |
| Net business purchase and sale | ---- | ---- | --0 | --0 | ---- | ---- | ---- | -139.36%-500K | --0 | --0 |
| Net investment purchase and sale | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | --0 | 98.60%-9.29K | --0 | 100.00%-2 | 98.14%-9.29K | --0 | 1.66%-661.8K | 95.37%-33.61K | -3,508.16%-128.2K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -92.73%338.52K | 838.24K | -56.42%4.65M | 176 | 0 | -12.44%4.65M | 0 | -29.13%10.68M | 0 | -117.31%-63.7K |
| Net common stock issuance | -92.41%396.15K | --1.03M | -56.42%4.65M | 100.15%1 | -782.54%-562.15K | 9.95%5.22M | --0 | -37.71%10.68M | -100.01%-646 | ---63.7K |
| Proceeds from stock option exercised by employees | ---- | ---- | -72.91%175 | ---- | ---- | ---- | ---- | --646 | ---- | ---- |
| Net other financing activities | ---57.63K | ---191.82K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -92.73%338.52K | --838.24K | -56.42%4.65M | --176 | --0 | -12.44%4.65M | --0 | -29.13%10.68M | --0 | -117.31%-63.7K |
| Net cash flow | ||||||||||
| Beginning cash position | -17.14%5.58M | -26.27%6.57M | 44.29%8.91M | -20.86%7.6M | -16.74%9.53M | -27.94%6.74M | 44.29%8.91M | -16.11%6.18M | 62.83%9.6M | 1.53%11.45M |
| Current changes in cash | -177.37%-2.16M | 54.53%-988.57K | -185.57%-2.34M | -48.80%-1.03M | -4.64%-1.93M | 33.04%2.8M | -168.51%-2.17M | 330.61%2.74M | -348.26%-691.54K | 65.65%-1.85M |
| End cash Position | -64.14%3.42M | -17.14%5.58M | -26.27%6.57M | -26.27%6.57M | -20.86%7.6M | -16.74%9.53M | -27.94%6.74M | 44.29%8.91M | 44.29%8.91M | 62.83%9.6M |
| Free cash flow | -34.71%-2.5M | 15.98%-1.83M | 6.04%-7M | -48.82%-1.03M | -8.38%-1.93M | 31.54%-1.86M | 3.61%-2.17M | 52.35%-7.45M | 82.91%-691.54K | 66.65%-1.78M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |